HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $299,000 | +30.6% | 2,694 | +39.8% | 0.01% | +16.7% |
| Q4 2020 | $229,000 | +6.0% | 1,927 | +12.6% | 0.01% | 0.0% |
| Q4 2019 | $216,000 | 0.0% | 1,711 | 0.0% | 0.01% | -53.8% |
| Q3 2019 | $216,000 | -43.3% | 1,711 | -46.0% | 0.03% | -38.1% |
| Q2 2019 | $381,000 | +38.0% | 3,170 | +0.3% | 0.04% | +35.5% |
| Q1 2019 | $276,000 | +20.0% | 3,160 | +37.7% | 0.03% | +10.7% |
| Q4 2018 | $230,000 | – | 2,295 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |